Press release
Verastem Oncology and STAAR Ovarian Cancer Foundation Establish the Inaugural Low-Grade Serous Ovarian Cancer (LGSOC) Awareness Day on September 9, 2024
LGSOC is a rare ovarian cancer often affecting younger women, with no FDA-approved treatments Approximately 80% of people treated for LGSOC will have their
About this update from Verastem, Inc.
[{"type":"text","content":"\nLGSOC is a rare ovarian cancer often affecting younger women, with no FDA-approved treatments\n\n\nApproximately 80% of people treated for LGSOC will have their cancer come back\n\n\n BOSTON & HOUSTON, Texas--(BUSINESS WIRE)--\nVerastem Oncology (Nasdaq: VSTM), a biopharmaceutical company committed to advancing new medicines for patients with cancer, and the STAAR Ovarian Cancer Foundation today announced the first Low-Grade Serous Ovarian Cancer Awareness Day or “LGSOC Awareness Day” on September 9, 2024.\n\nThis press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240903051307/en/\nSeptember is Ovarian Cancer Awareness Month and LGSOC is a rare ovarian cancer with little information and awareness available to patients and caregivers. This newly created annual LGSOC Awareness Day will educate people about the symptoms of LGSOC, provide resources to people diagnosed with LGSOC, and advocate for more research.\n\n\n“When I was diagnosed with LGSOC I knew nothing about this rare ovarian cancer and found that very little information existed about the disease. It is one of my goals to ensure that the first-ever LGSOC Awareness Day will bring much-needed awareness and attention to this rare ovarian cancer so that no person diagnosed with this disease feels alone,” said Nicole Andrews, Board of Directors Chair, STAAR Ovarian Cancer Foundation. “Currently, there are limited treatment options available for LGSOC and no FDA-approved treatments specifically for LGSOC. As the first U.S. foundation dedicated to funding LGSOC research, we want to do more to elevate the unmet needs for this disease and give patients living with LGSOC a voice in the ovarian cancer conversation.”\n\n\nTo help raise awareness and participate in the first LGSOC Awareness Day on Monday, September 9:\n\n\n\nVisit STAAR’s website (https://www.staaroc.org/lgsoc-awareness-day.html) to download shareable social media content and use the hashtag #LGSOCAwarenessDay in their posts.\n\n\n\nLearn more about LGSOC and access tools and resources by visiting Verastem’s Let’s Talk About LGSOC website (https://letstalkaboutlgsoc.com/).\n\n\n\n“The inaugural LGSOC Awareness Day builds on the recognition of LGSOC as a distinct disease that is different from other ovarian cancers,” said Dan Paterson, president and chief executive...